BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29515448)

  • 1. Autoradiography of
    Valuskova P; Farar V; Forczek S; Krizova I; Myslivecek J
    Front Pharmacol; 2018; 9():124. PubMed ID: 29515448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic comparison of muscarinic M1 and M2 binding sites in the CNS of spontaneously hypertensive and normotensive rats.
    Gattu M; Pauly JR; Urbanawiz S; Buccafusco JJ
    Brain Res; 1997 Oct; 771(2):173-83. PubMed ID: 9401737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor M1 and M2 subtypes in the human eye: QNB, pirenzipine, oxotremorine, and AFDX-116 in vitro autoradiography.
    Gupta N; McAllister R; Drance SM; Rootman J; Cynader MS
    Br J Ophthalmol; 1994 Jul; 78(7):555-9. PubMed ID: 7918268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic cholinergic receptor subtypes in human detrusor muscle studied by labeled and nonlabeled pirenzepine, AFDX-116 and 4DAMP.
    Kondo S; Morita T; Tashima Y
    Urol Int; 1995; 54(3):150-3. PubMed ID: 7604457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrotrapezoid nucleus muscarinic receptor subtypes localized by autoradiography.
    Nattie EE; Li A; Mills J; Huang Q
    Respir Physiol; 1994 May; 96(2-3):189-97. PubMed ID: 8059083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography.
    Vilaró MT; Wiederhold KH; Palacios JM; Mengod G
    Neuroscience; 1992; 47(2):367-93. PubMed ID: 1641129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia.
    Vanderheyden P; Ebinger G; Dierckx R; Vauquelin G
    J Neurol Sci; 1987 Dec; 82(1-3):257-69. PubMed ID: 3440867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors.
    Purkerson SL; Potter LT
    J Pharmacol Exp Ther; 1998 Feb; 284(2):707-13. PubMed ID: 9454818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies.
    Araujo DM; Lapchak PA; Quirion R
    Synapse; 1991 Nov; 9(3):165-76. PubMed ID: 1776129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic cholinergic receptors in the rat caudate-putamen and olfactory tubercle belong predominantly to the m4 class: in situ hybridization and receptor autoradiography evidence.
    Vilaró MT; Wiederhold KH; Palacios JM; Mengod G
    Neuroscience; 1991; 40(1):159-67. PubMed ID: 2052149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
    Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA
    Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of oxomemazine for the M1 muscarinic receptors.
    Lee SW; Woo CW; Kim JG
    Arch Pharm Res; 1994 Dec; 17(6):443-51. PubMed ID: 10319156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and quantitative autoradiographic distribution of [3H]acetylcholine muscarinic receptors in mammalian brain. Apparent labelling of an M2-like receptor sub-type.
    Quirion R; Araujo D; Regenold W; Boksa P
    Neuroscience; 1989; 29(2):271-89. PubMed ID: 2725859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.
    Messer WS; Ellerbrock BR; Smith DA; Hoss W
    J Med Chem; 1989 Jun; 32(6):1164-72. PubMed ID: 2724292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.